Gapping up
In reaction to strong earnings/guidance:
- CAG +12.9%, XLNX +7% (guides JunQ and SepQ above consensus), MU +6.2%, JEF +5.8%
M&A news:
- LULU +4.1% (to acquire in-home fitness company MIRROR for $500 mln)
Other news:
- BLNK +58.1% (extends momentum)
- NLS +10% (in sympathy with LULU acquiring home fitness co Mirror)
- IFRX +7.7% (is now assessing different strategies for a potential pathway to regulatory approval for IFX-1 in the United States and plans to engage with the FDA on next steps)
- SPG +7.2% (provides reopening update; declares Q2 dividend of $1.30)
- ARYA +4.7% (shareholders approve combo with Immatics Biotech)
- WDC +3.1% (in sympathy with strong MU earnings)
- SGEN +2.8% (announces "favorable" results from Phase 2 trial of tisotumab vedotin)
- MRNS +2% (provided a pipeline update)
- GMAB +1.3% (announces "favorable" results from Phase 2 trial of tisotumab vedotin)
Analyst comments:
- CROX +3% (upgraded to Buy from Hold at Loop Capital)
- HOLX +1.6% (upgraded to Outperform from Market Perform at Cowen)
- TOL +1.6% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
- ACRE +1.4% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
- TME +1.1% (upgraded to Buy from Neutral at UBS)